Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose hCG vs Double Trigger for Oocyte Maturation in IVF
NCT02368964Completed
- Sponsor
- Sheba Medical Center
- Start
- Feb 2015
- Primary completion
- Jun 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of triptorelin and recombinant human chorionic gonadotrophin in infertility (2 arms), sponsored by Sheba Medical Center. Primary endpoint: Number MII oocytes per number of oocytes retrieved. Started Feb 2015; status: completed.
02
Drugs
triptorelinrecombinant human chorionic gonadotrophin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT02368964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02368964.